ARHGEF28
Basic information
Region (hg38): 5:73626158-73941993
Links
Phenotypes
GenCC
Source:
- amyotrophic lateral sclerosis (Moderate), mode of inheritance: AD
- amyotrophic lateral sclerosis (Moderate), mode of inheritance: AR
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ARHGEF28 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 11 | 13 | 24 | |||
missense | 133 | 17 | 14 | 164 | ||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 2 | 1 | 1 | 4 | ||
non coding | 77 | 80 | ||||
Total | 0 | 0 | 135 | 30 | 104 |
Variants in ARHGEF28
This is a list of pathogenic ClinVar variants found in the ARHGEF28 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
5-73684549-T-G | Benign (Jun 19, 2021) | |||
5-73684867-A-C | not specified | Uncertain significance (Oct 08, 2024) | ||
5-73684870-G-A | ARHGEF28-related disorder | Uncertain significance (Dec 05, 2022) | ||
5-73685012-G-A | Benign (Jun 18, 2021) | |||
5-73685044-G-C | Benign (Jun 18, 2021) | |||
5-73749597-G-C | Benign (Jun 18, 2021) | |||
5-73749654-A-G | Benign (Jun 19, 2021) | |||
5-73749681-T-C | Benign (Jun 18, 2021) | |||
5-73749839-G-A | ARHGEF28-related disorder | Likely benign (Jun 06, 2019) | ||
5-73749843-A-G | not specified | Uncertain significance (Apr 24, 2024) | ||
5-73749936-A-G | ARHGEF28-related disorder • not specified | Likely benign (Apr 07, 2023) | ||
5-73749949-G-A | not specified | Uncertain significance (Aug 27, 2024) | ||
5-73752926-A-T | not specified | Uncertain significance (Jan 12, 2024) | ||
5-73752927-C-T | ARHGEF28-related disorder | Likely benign (Sep 20, 2017) | ||
5-73752928-G-A | ARHGEF28-related disorder | Likely benign (Apr 20, 2022) | ||
5-73752977-A-G | not specified | Uncertain significance (Aug 02, 2021) | ||
5-73752992-G-C | not specified | Uncertain significance (Oct 29, 2021) | ||
5-73752994-G-A | not specified | Benign (-) | ||
5-73753001-G-A | ARHGEF28-related disorder | Uncertain significance (Aug 01, 2024) | ||
5-73753041-C-T | not specified | Uncertain significance (Nov 22, 2024) | ||
5-73753042-G-T | not specified | Benign/Likely benign (Dec 31, 2019) | ||
5-73753050-A-G | Benign (May 01, 2023) | |||
5-73753079-C-T | ARHGEF28-related disorder | Likely benign (Feb 15, 2023) | ||
5-73753087-C-T | ARHGEF28-related disorder | Likely benign (May 31, 2023) | ||
5-73753101-C-T | not specified | Uncertain significance (Jan 10, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ARHGEF28 | protein_coding | protein_coding | ENST00000545377 | 36 | 315836 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
8.10e-21 | 1.00 | 124544 | 1 | 118 | 124663 | 0.000477 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.734 | 823 | 884 | 0.931 | 0.0000485 | 11235 |
Missense in Polyphen | 200 | 254.12 | 0.78702 | 3426 | ||
Synonymous | 1.61 | 313 | 351 | 0.890 | 0.0000209 | 3275 |
Loss of Function | 3.83 | 47 | 85.1 | 0.552 | 0.00000435 | 1083 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00102 | 0.00101 |
Ashkenazi Jewish | 0.000202 | 0.000199 |
East Asian | 0.000626 | 0.000612 |
Finnish | 0.000139 | 0.000139 |
European (Non-Finnish) | 0.000357 | 0.000345 |
Middle Eastern | 0.000626 | 0.000612 |
South Asian | 0.00124 | 0.00118 |
Other | 0.000340 | 0.000330 |
dbNSFP
Source:
- Function
- FUNCTION: Functions as a RHOA-specific guanine nucleotide exchange factor regulating signaling pathways downstream of integrins and growth factor receptors. Functions in axonal branching, synapse formation and dendritic morphogenesis. Functions also in focal adhesion formation, cell motility and B-lymphocytes activation. May regulate NEFL expression and aggregation and play a role in apoptosis (By similarity). {ECO:0000250}.;
- Pathway
- Developmental Biology;EPH-Ephrin signaling;EPHB-mediated forward signaling;Axon guidance;Signaling events mediated by focal adhesion kinase;Regulation of RhoA activity
(Consensus)
Intolerance Scores
- loftool
- rvis_EVS
- -0.27
- rvis_percentile_EVS
- 34.32
Haploinsufficiency Scores
- pHI
- hipred
- N
- hipred_score
- 0.462
- ghis
- 0.459
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- gene_indispensability_score
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | High | High | High |
Primary Immunodeficiency | High | High | High |
Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Arhgef28
- Phenotype
- normal phenotype; growth/size/body region phenotype; cellular phenotype;
Zebrafish Information Network
- Gene name
- arhgef28a
- Affected structure
- fast muscle cell
- Phenotype tag
- abnormal
- Phenotype quality
- disorganized
Gene ontology
- Biological process
- cell differentiation;regulation of Rho protein signal transduction;intracellular signal transduction;ephrin receptor signaling pathway
- Cellular component
- cytosol;plasma membrane
- Molecular function
- RNA binding;guanyl-nucleotide exchange factor activity;Rho guanyl-nucleotide exchange factor activity;metal ion binding